tiprankstipranks

Oncolytics reports Q3 EPS (8c), consensus (8c)

$32.4M in cash and cash equivalents as of September 30 provides projected runway through key milestones to the end of 2023.

Confident Investing Starts Here:

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on ONCY:

Disclaimer & DisclosureReport an Issue